Skip to main content
University of Wisconsin–Madison
Jillian Kyzer, a medicinal chemist and staff scientist in the School of Pharmacy, synthesizes a chemical reaction as part of her work in the Wenthur Lab, which explores how psychedelics can improve mental health disorders. The investment from WARF will help fund research to produce foundational data around brain health. PHOTO: SHARON VANORNY

WARF announces 2026 UW–Madison research investment

Wisconsin Alumni Research Foundation announces 2026 investment in research at UW–Madison

The U.S. National Science Foundation renews NSF IceCube operation and maintenance contract

42 faculty receive 2026-27 WARF Named Professorship, Kellett Fellowships and H.I. Romnes Awards

UW Distinguished Research Fellows Program is in full swing

Read WARF story

Discover Research

UW Research at a Glance

  • 5th
    in nation for volume of research
  • $1.93B
    spent on research
  • 19
    VCR research and service centers
IceCube at South Pole

Research Innovation at UW–Madison Overview

SSEC rooftop

Learn about VCR research centers

Biotech Bucky

Industry Partnerships

Apply for research funding and grants

n the late 1950s, Kay Emerson became the first person in Wisconsin to be successfully treated for phenylketonuria (PKU), a rare metabolic condition that can cause severe intellectual and developmental disability if left untreated. She was treated by Harry Waisman, MD, PhD, who was a renowned PKU researcher and physician and who the Waisman Center is named after. He advocated to add PKU to the Newborn Screening Panel in Wisconsin.

Centers in the news

Yang Lu headshot

New Faculty